Re: DECLARE TIMI-58 w/ prior MI as BETonMACE proxy?
|
4
|
Resverlogix Corp.
|
Mar 28, 2019 02:58PM
|
Resverlogix poster from ASN 2016
|
4
|
Resverlogix Corp.
|
Nov 21, 2016 12:57PM
|
Re: Financials are out
|
4
|
Resverlogix Corp.
|
Jul 31, 2018 09:14AM
|
Re: Does anyone have a link to the patent application?
|
4
|
Resverlogix Corp.
|
May 23, 2017 12:48PM
|
Re: Resverlogix to Present at the European Society of Cardiology’s ESC Congress 2019
|
4
|
Resverlogix Corp.
|
Aug 31, 2019 08:34AM
|
Re: Is CellCentric a competitor?
|
4
|
Zenith Epigenetics
|
May 15, 2018 10:47PM
|
Re: I would have thought we'd see more volume....
|
4
|
Resverlogix Corp.
|
Sep 14, 2018 08:05AM
|
Re: While we wait, outside items that may be of interest
|
4
|
Resverlogix Corp.
|
Aug 27, 2017 08:09AM
|
New Blog Post-First of Three in Series on Complement System
|
4
|
Resverlogix Corp.
|
Oct 21, 2015 06:08PM
|
Re: BETonMACE baseline data
|
4
|
Resverlogix Corp.
|
Nov 05, 2018 03:12PM
|
Re: Amarin Stock Halted pending FDA meeting today
|
4
|
Resverlogix Corp.
|
Nov 14, 2019 10:29AM
|
Tick tock
|
4
|
Resverlogix Corp.
|
Aug 11, 2017 11:22AM
|
Re: BIO Investor Forum, Oct 22-23
|
4
|
Zenith Epigenetics
|
Oct 23, 2019 06:38PM
|
Final Checklist for Management
|
4
|
Resverlogix Corp.
|
Jul 28, 2016 05:19PM
|
Resverlogix's 2017 Outlook Video
|
4
|
Resverlogix Corp.
|
Feb 09, 2017 04:41PM
|
Re: Share Price
|
4
|
Resverlogix Corp.
|
Jan 04, 2019 12:07PM
|
Re: One point I want to make clear...
|
4
|
Resverlogix Corp.
|
Feb 15, 2019 12:15PM
|
Resverlogix’ BETonMACE Phase 3 Trial Successfully Reaches its Targeted 250 MACE Events
|
4
|
Resverlogix Corp.
|
Apr 18, 2019 08:21AM
|
Re: H1 2020 Potential Events
|
4
|
Resverlogix Corp.
|
Mar 24, 2020 09:42PM
|
Re: Question for Kelsee or anyone else who might know
|
4
|
Resverlogix Corp.
|
Dec 12, 2018 04:08PM
|